DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global 3D Bioprinters Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2012 to 2022" report to their offering.
The 3D bioprinters market is expected to reach USD 1,942.5 Mn by 2022, extending at a CAGR of 18.8% from 2016 to 2022.
3D bioprinting is the procedure that permits scientists to produce and collect cell layers to frame natural tissues. The utilization of biomaterial cells, proteins or other organic mixes as building square is completed for creating 3D customized structures or in vitro natural models through added substance fabricating forms. The central point driving 3D bioprinters market are expanding interest for organ transplants, and necessity of cost-proficient advances in medication improvement. As indicated by the Organ Procurement and Transplantation Network (OPTN) and the Gift of Life Donor Program, in the U.S., a normal of 21 individuals pass on consistently sitting tight for an organ transplant, and the hold up times can run from four months for a heart to five years for a kidney.
The worldwide 3D bioprinters market is spoken to by key advancements to be specific, syringe based 3D bioprinting, laser based 3D bioprinting, attractive levitation 3D bioprinting, inkjet based 3D bioprinting furthermore, valve-based 3D bioprinting. Among these syringe based 3D bioprinting is the biggest fragment and is expected to keep up its lead amid the gauge time frame 2016 - 2022. Pharmaceuticals fragment represented a noteworthy offer of 31.70% in the 3D bioprinting market. Drug improvement today is progressively concentrating on decreasing symptoms, enhancing treatment results and betraying the 'one-size-fits-all' way to deal with pharmaceutical administration.
Key Market Movements:
- Gap between patients sitting tight for organ transplant and accessible organ benefactors.
- Rising interest for cost-productive innovations in medication improvement forms.
- Growth in appropriation of 3D bio-printed bone unions and dental consumables.
- BioBots, Inc.
- TeVido BioDevices, LLC
- 3D Dynamic Systems Ltd.
- Rokit, Inc.
- Aspect Biosystems Ltd.
- Cyfuse Biomedical K.K.
- Organovo Holdings, Inc.
- Stratasys Ltd.
- 3D Systems, Inc.
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 3D Bioprinters Market: Market Dynamics and Outlook
Chapter 4 Global 3D Bioprinters Market, by Technology
Chapter 5 Global 3D Bioprinters Market, by Application
Chapter 6 Global 3D Bioprinters Market, By Geography
Chapter 7 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/llm4gh/global_3d